<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00622986</url>
  </required_header>
  <id_info>
    <org_study_id>XMT-5Cs-002-2007</org_study_id>
    <nct_id>NCT00622986</nct_id>
  </id_info>
  <brief_title>China Cimicifuga Trial of Climacteric Complaint Control</brief_title>
  <acronym>CCCCC</acronym>
  <official_title>A Multicentered RCT Study of the Efficacy and Safety of an Extract of Cimicifuga Foetida L. for the Treatment of Climacteric Symptoms of Chinese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong Luye Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong Luye Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine whether an extract of Cimicifuga Foetida L. is safe and
      efficacious to relieve the climacteric symptoms of Chinese women
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extracts of Cimicifuga Racemosa (black cohosh) have been widely used in North America and
      Europe for decades for the treatment of menopause related problems, either as nutritional
      supplements or as pharmaceutical products. Previous clinical trials had shown that an extract
      of Cimicifuga Foetida L.(Ximingting, Luyepharm), which was standardized to have similar
      components of an extract of Cimicifuga Racemosa, was safe and efficacious to relieve the
      climacteric symptoms and signs in Chinese women who were recruited according to criteria
      categorized by theory of Traditional Chinese Medicine.We are interested to know whether it
      may have the same efficacy and safety profiles when judged with method and standard commonly
      accepted in western medicine.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of scores of Kupperman Index before and after the treatment</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of scores of Menopause Rating Scale before and after the treatment</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Climacteric Symptoms</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>perimenopausal women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>perimenopausal women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>early staged postmenopausal women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>early staged postmenopausal women</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>an extract of Cimicifuga Foetida L.</intervention_name>
    <description>Each patient will be given the medication of extract of Cimicifuga Foetida L. 2 tablets each day for 3 months.</description>
    <arm_group_label>B1</arm_group_label>
    <other_name>Ximingting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>an extract of Cimicifuga Foetida L.</intervention_name>
    <description>Each patient will be given the medication of extract of Cimicifuga Foetida L. 2 tablets each day for 3 months.</description>
    <arm_group_label>A1</arm_group_label>
    <other_name>Ximingting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Each patient will be given placebo of 2 tablets each day for 3 months.</description>
    <arm_group_label>A2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Each patient will be given placebo of 2 tablets each day for 3 months.</description>
    <arm_group_label>B2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Having climacteric symptoms with hot flushes &gt;= 3 time per day

          -  Score of Kupperman Index at baseline &gt;= 20

          -  In addition to these criteria, women who had menopause longer than 2 months but less
             than 12 months, with FSH &gt; 15U/L were enrolled into the perimenopausal group. Women
             having menopause longer than 12 months but less than 5 years, with FSH &gt;= 40U/L and E2
             &lt;= 30pg/ml, were assigned into early staged postmenopausal group.

        Exclusion Criteria:

          -  Having history of hysterectomy

          -  Having HRT within 6 weeks

          -  Having other drugs or nutritional supplements of relieving climacteric symptoms within
             one week

          -  Having psychological counseling within one week

          -  Having medical history of estrogen-dependent tumors

          -  The result of pap smear exam at stage III and above

          -  Having an uterine leiomyoma lager than 4 cm

          -  The endometrial thickness lager than 0.5 cm

          -  Having abnormal cardiac, liver or kidney functions

          -  Having abnormal thyroid function

          -  Having hypertension, diabetes and coronary heart diseases that were not under control

          -  Pregnant or suspected pregnant woman

          -  Having severe mental disorders that inhibit to understand the research purpose

          -  Other conditions the investigators believed not suitable for enrollment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shouqing Lin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Union Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shouqing Lin, MD</last_name>
    <phone>86-10-88068846</phone>
    <email>shouqing_lin2003@yahoo.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fujian Provincal Maternal and Children Health Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuan Lin, MD</last_name>
      <phone>86-591-88892678</phone>
      <phone_ext>0</phone_ext>
      <email>Alice-96@163.com</email>
    </contact>
    <investigator>
      <last_name>Yuan Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospitalï¼ŒSUN YAT-SEN University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuzhong Yao, MD</last_name>
      <phone>86-20-87332200</phone>
      <phone_ext>8342</phone_ext>
      <email>yszlfy@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Liping Feng, MD</last_name>
      <phone>86-20-87332200</phone>
      <phone_ext>8342</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Shuzhong Yao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongnan University Xiangya No.3. Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Xue, MD</last_name>
      <phone>86-731-8618040</phone>
      <phone_ext>0</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Xinliang Deng, MD</last_name>
      <phone>86-731-8618560</phone>
      <phone_ext>0</phone_ext>
      <email>lovezz_dxl@yeah.net</email>
    </contact_backup>
    <investigator>
      <last_name>Min Xue, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongnan University Xiangya No.2. Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunnan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fengzhi Liu, MD</last_name>
      <phone>86-731-5295219</phone>
      <phone_ext>0</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Hongwen Zhang, MD</last_name>
      <phone>86-731-5295007</phone>
      <phone_ext>0</phone_ext>
      <email>zhw6216@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fengzhi Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongli Yang, MD</last_name>
      <phone>86-531-87938911</phone>
      <phone_ext>6380</phone_ext>
      <email>yangzhongli121@sina.com</email>
    </contact>
    <investigator>
      <last_name>Zhongli Yang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Medical School Hospital Of Qingdao University</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuping Zhao, MD</last_name>
      <phone>86-532-82911314</phone>
      <email>zhaoshuping2006@163.com</email>
    </contact>
    <investigator>
      <last_name>Shuping Zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bejing Union Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shouqing Lin, MD</last_name>
      <phone>86-10-88068846</phone>
      <email>shouqing_lin2003@yahoo.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Aijun Sun, MD</last_name>
      <phone>86-10-88068848</phone>
      <email>sunaj25@sina.com</email>
    </contact_backup>
    <investigator>
      <last_name>Shouqing Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Great Wall Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Song, MD</last_name>
      <phone>86-10-66939351</phone>
      <email>songl301@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Wensheng Fan, MD</last_name>
      <phone>86-10-66937254</phone>
    </contact_backup>
    <investigator>
      <last_name>Lei Song, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiqing Liang, MD</last_name>
      <phone>86-23-68754409</phone>
      <phone_ext>0</phone_ext>
      <email>zhi.Lzliang@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cheng Chen, MD</last_name>
      <phone>86-23-68754409</phone>
      <phone_ext>0</phone_ext>
      <email>chencheng961@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zhiqing Liang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Daping Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Li, MD</last_name>
      <phone>86-23-68757310</phone>
      <email>xglili@mail.dph-fsi.com</email>
    </contact>
    <investigator>
      <last_name>Li Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Obstetrics &amp; Gynecology Hospital Of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Congjuan Cheng, MD</last_name>
      <phone>+8613788965050</phone>
      <phone_ext>6684</phone_ext>
      <email>chengcongjuan@163.com</email>
    </contact>
    <investigator>
      <last_name>Congjuan Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Peace Maternity &amp; Child Health Hospital Of The China Welfare Institute</name>
      <address>
        <city>Shanghai</city>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kun Qi, MD</last_name>
      <phone>86-21-64070434</phone>
      <phone_ext>25517</phone_ext>
      <email>ipmch_kjk@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Kun Qi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin City Hospital for Gynaecology and Obsterics</name>
      <address>
        <city>Tianjin</city>
        <zip>300025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanjun Lin, MD</last_name>
      <phone>86-22-23043612</phone>
      <email>linwanjun5835@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Wanjun Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2008</study_first_submitted>
  <study_first_submitted_qc>February 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2008</study_first_posted>
  <last_update_submitted>February 22, 2008</last_update_submitted>
  <last_update_submitted_qc>February 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Lin Shouqing</name_title>
    <organization>Beijing Union Hospital</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

